respiratori
tract
infect
among
common
present
complaint
patient
hospit
commun
set
consider
burden
term
patient
morbid
public
health
intervent
laboratori
diagnosi
respiratori
tract
infect
provid
guidanc
therapi
prognosi
well
use
epidemiolog
inform
reflect
trend
commun
understand
monitor
trend
facilit
earli
recognit
new
infecti
agent
popul
summari
common
virus
bacteria
caus
respiratori
tract
infect
clinic
relev
given
tabl
respect
even
signific
clinic
effort
analysi
multipl
specimen
current
laboratori
method
fail
diagnos
approxim
half
lower
respiratori
tract
infect
fact
laboratori
diagnosi
communityacquir
pneumonia
cap
poor
current
clinic
practic
guidelin
recommend
test
sever
affect
patient
advis
use
empir
therapi
pragmat
approach
fail
address
issu
antimicrobi
overus
resist
public
health
surveil
advanc
medic
knowledg
mani
atyp
bacteria
known
caus
sever
respiratori
symptom
lack
good
diagnost
procedur
hamper
measur
real
impact
infect
commun
despit
vaccin
polici
bordetella
pertussi
infect
remain
rel
common
children
adult
associ
chronic
cough
adult
mycoplasma
pneumonia
legionella
pneumophila
chlamydophilia
previous
chlamydia
pneumonia
recogn
caus
lower
respiratori
tract
infect
impact
studi
detail
addit
despit
wellrecogn
associ
viral
infect
upper
lower
respiratori
tract
infect
current
diagnost
virolog
procedur
provid
answer
rapidli
enough
parainfluenza
viru
type
human
coronavirus
rhinovirus
enterovirus
would
ordinarili
identifi
without
rna
detect
method
impact
infect
realiz
probabl
underestim
clinic
import
particularli
immunocompromis
individu
elderli
underli
condit
asthma
human
metapneumoviru
confirm
import
caus
sever
lower
respiratori
tract
infect
viru
circul
year
studi
use
molecular
assay
confirm
wide
distribut
mani
laboratori
success
isol
viru
recent
identif
agent
caus
sever
acut
respiratori
syndrom
sar
known
sarscov
illustr
need
expans
diagnost
test
encompass
new
emerg
virus
limit
convent
virolog
laboratori
approach
respiratori
pathogen
diagnosi
even
possibl
cultur
virus
effici
isol
confirm
caus
cytopath
effect
take
day
week
depend
pathogen
wait
cultureposit
result
take
mani
day
time
patient
may
inappropri
treat
hospit
infect
control
measur
may
initi
also
use
primari
primat
cell
cultur
give
best
yield
influenza
parainfluenza
virus
unlik
sustain
long
term
avail
monoclon
antibodi
use
direct
virusspecif
antigen
detect
test
use
rapid
diagnosi
mani
laboratori
abl
provid
diagnost
test
influenza
parainfluenza
type
respiratori
syncyti
viru
rsv
respiratori
adenovirus
respiratori
specimen
contain
cell
necessari
sensit
detect
virus
immunofluoresc
antigendetect
method
goodqual
diagnost
sampl
often
lavag
aspir
sampl
usual
obtain
young
immunocompet
hospit
individu
circumst
ideal
sampl
may
avail
delay
transport
may
reduc
specimen
qualiti
compromis
assay
result
mostdifficult
leasteffici
specimen
diagnost
test
swab
sampl
contain
minim
cellular
materi
taken
larg
asymptomat
individu
commun
smear
sampl
difficult
interpret
direct
antigen
test
thu
cultur
sampl
usual
requir
pathogen
identif
bacteri
antigen
detect
direct
fluoresc
antibodi
dfa
test
similarli
compromis
poor
sensit
ad
concern
artifact
lead
falseposit
result
particularli
b
pertussi
l
pneumophila
serolog
assay
antibodi
respons
infect
avail
respiratori
pathogen
although
use
retrospect
evid
infect
commun
result
time
enough
patient
manag
cellassoci
intracellular
bacteria
virus
antibodi
respons
develop
slowli
develop
convalesc
sera
taken
mani
week
diseas
onset
requir
make
definit
diagnosi
eg
c
pneumonia
legionella
speci
rsv
infect
influenza
antibodi
respons
brisk
frequent
reinfect
reduc
igm
respons
convalesc
sera
requir
demonstr
chang
titer
limit
convent
test
well
recogn
viral
bacteri
pathogen
key
differ
nucleic
acid
cultur
direct
antigen
test
method
summar
tabl
util
rapid
viral
diagnost
procedur
may
provid
molecular
amplif
method
could
help
reduc
emerg
antibioticresist
bacteria
one
studi
demonstr
reduct
antibiot
use
possibl
use
molecular
method
viral
diagnosi
despit
obviou
econom
burden
cap
accur
data
mani
infect
viral
origin
caus
atyp
bacteria
routin
diagnost
test
readili
avail
identif
emerg
human
viral
infect
influenza
sarscov
heighten
awar
gap
respiratori
pathogen
diagnosi
nucleic
acid
detect
assay
like
util
wide
identifi
novel
emerg
pathogen
could
result
worldwid
outbreak
molecular
amplif
assay
use
success
identif
organ
associ
pneumonia
potenti
nosocomi
spread
respiratori
pathogen
well
recogn
patient
admit
hospit
rsv
parainfluenza
infect
serv
reservoir
transmiss
vulner
patient
lead
possibl
outbreak
previous
avail
diagnost
method
sensit
enough
identifi
sourc
outbreak
advent
molecular
amplif
method
allow
even
environment
sampl
help
confirm
outbreak
sourc
link
cluster
case
infect
sampl
use
detect
respiratori
pathogen
includ
swab
usual
nasopharyng
throat
aspir
nasopharyng
tracheal
sputum
usual
individu
present
pneumonia
bronchoalveolar
lavag
specimen
infect
involv
entir
respiratori
tract
nasopharyng
specimen
practic
diagnosi
infect
focal
meltingcurv
analysi
pcr
product
use
intercal
dye
sybr
green
differenti
specif
nonspecif
product
without
manipul
pcr
product
specif
sequenc
inform
requir
catchal
approach
may
advantag
novel
design
triag
test
difficult
pathogen
need
identifi
gener
primer
may
use
identifi
novel
pathogen
sensit
exquisit
sensit
prone
gener
less
sensit
nucleic
acid
detect
method
crosscontamin
problem
specif
care
handl
requir
avoid
care
handl
requir
avoid
contamin
contamin
common
problem
lesscommon
problem
molecular
method
dfa
primerprob
design
crucial
subject
interpret
strain
type
definit
method
limit
serotyp
eg
influenza
legionella
autom
autom
extract
equip
becom
difficult
autom
avail
autom
detect
commonplac
safeti
inactiv
analysi
antimicrobi
isol
use
antimicrobi
sensit
test
sensit
inform
requir
knowledg
phenotyp
special
safeti
requir
need
genotyp
mutat
cultur
categori
pathogen
qualiti
assur
profici
valid
method
well
cultur
depend
critic
cell
line
medium
qualiti
establish
maintain
qualiti
difficult
lower
respiratori
tract
specimen
requir
eg
legionella
sampl
prepar
critic
step
detect
analysi
organ
numer
method
simpl
boil
sophist
autom
protocol
avail
disrupt
organ
purif
nucleic
acid
mani
studi
demonstr
inhibitor
respiratori
specimen
make
form
extract
without
freez
necessari
avoid
frequent
fals
neg
result
commerci
kit
prepar
sampl
avail
reduc
interlaboratori
variat
result
simultan
extract
rna
dna
facilit
assay
virus
bacteria
molecular
techniqu
detect
analysi
pathogen
associ
respiratori
infect
provid
specif
diagnos
individu
case
outbreak
current
fdaclear
molecular
test
avail
detect
respiratori
pathogen
except
mycobacterium
tuberculosi
see
chapter
molecular
test
perform
use
either
valid
laboratorydevelop
procedur
commerci
test
reagent
publish
diagnost
method
detect
respiratori
pathogen
dna
rna
directli
clinic
specimen
util
target
amplif
procedur
polymeras
chain
reaction
pcr
nucleic
acid
sequencebas
amplif
nasba
although
direct
detect
method
base
nucleic
acid
hybrid
would
theoret
possibl
amount
target
nucleic
acid
specimen
may
minim
method
would
lack
sensit
compar
amplif
method
unless
organ
propag
analysi
thu
molecular
amplif
procedur
report
direct
detect
respiratori
pathogen
clinic
sampl
includ
pcr
eg
refer
figur
assay
util
bacteri
ribosom
rna
rrna
eg
refer
cellular
sampl
test
respiratori
pathogen
target
messeng
rna
mrna
genom
antisens
rna
may
enhanc
diagnost
sensit
varieti
format
util
detect
amplifi
product
procedur
separ
target
amplif
detect
phase
agaros
gel
analysi
endpoint
hybrid
well
establish
may
allow
multipl
target
analyz
singl
reaction
provid
ad
type
inform
eas
use
incorpor
diagnost
laboratori
laboratorydevelop
assay
detect
respiratori
pathogen
util
realtim
amplif
method
amplif
detect
step
combin
method
use
intercal
dye
analysi
pcr
product
melt
temperatur
eg
describ
previous
illustr
figur
wherea
other
use
fluorogen
primer
probe
eg
taqman
hybrid
format
molecular
beacon
ensur
specif
reaction
figur
illustr
realtim
rtpcr
assay
sarscov
use
probespecif
detect
amplifi
product
one
fluoresc
measur
per
cycl
rang
realtim
pcr
rtpcr
nasba
methodolog
use
respiratori
target
divers
given
fact
assay
laboratori
develop
difficulti
diagnosi
respiratori
infect
wide
rang
pathogen
similar
present
nucleic
acid
technolog
util
current
major
diagnost
laboratori
realtim
pcr
singletarget
assay
case
gener
primer
design
pick
sever
relat
pathogen
gener
primer
may
base
conserv
protein
code
sequenc
essenti
enzym
function
noncod
region
variat
limit
need
mainten
secondari
structur
use
primer
set
pick
genera
even
famili
organ
shown
promis
limit
studi
includ
analysi
legionella
mycobacteria
gener
assay
abil
detect
mani
relat
organ
may
use
character
previous
undescrib
speci
respiratori
infect
limit
multiplex
procedur
report
detect
relat
organ
use
realtim
pcr
nasba
procedur
assay
difficult
set
control
mani
respiratori
pathogen
suffici
variat
multiplex
approach
develop
detect
exampl
possibl
respiratori
adenoviru
influenza
parainfluenza
type
simpl
duallabel
multiplex
nasba
assay
shown
figur
use
separ
primer
set
specif
molecular
beacon
probe
parainfluenza
type
reaction
mix
probe
label
differ
fluorophor
allow
detect
differenti
virus
singl
reaction
ambiti
multiplex
nest
rtpcr
procedur
gel
analysi
amplicon
detect
influenza
b
c
virus
rsv
b
subtyp
adenovirus
singl
assay
procedur
complex
set
valid
report
good
specif
better
sensit
antigencultur
procedur
interpret
valid
neg
result
import
part
diagnost
test
base
nucleic
acid
amplif
assay
incorpor
intern
control
system
distinguish
trueneg
falseneg
result
intern
control
may
amplifi
pathogenspecif
primer
result
amplicon
differ
size
intern
sequenc
pathogen
amplicon
altern
intern
control
may
extern
sequenc
spike
reaction
heterolog
control
amplifi
primer
set
differ
pathogen
primer
exampl
shown
figur
amplif
rna
heterolog
control
consist
across
mani
clinic
sampl
ensur
gross
inhibitor
present
reaction
cellular
sampl
obtain
detect
respiratori
pathogen
intern
control
reaction
util
human
dna
rrna
mrna
detect
approach
ad
valu
assess
sampl
collect
integr
well
amplif
inhibitor
rel
merit
commerci
versu
laboratorydevelop
test
depend
laboratori
facil
technic
expertis
avail
clinic
need
expand
diagnosi
commerci
test
reagent
provid
qualiti
control
procedur
standard
facilit
clinic
studi
mani
compani
focus
provid
analytespecif
reagent
asr
respiratori
pathogen
assay
asr
provid
laboratori
qualitycontrol
primer
probe
allow
flexibl
test
current
known
circul
pathogen
accord
local
test
algorithm
microarraybas
detect
multiplex
pcr
product
also
report
classic
type
bacteria
virus
use
serolog
techniqu
reli
antibodyantigen
interact
one
benefit
approach
base
dna
rna
detect
moredetail
quantit
assess
relationship
organ
provid
valuabl
data
relev
outbreak
investig
commun
health
variat
nucleic
acid
sequenc
level
necessarili
reflect
alter
protein
sequenc
function
thu
addit
sequenc
variat
inform
may
correl
convent
type
method
restrict
fragment
length
polymorph
rflp
analysi
puls
field
gel
electrophoresi
pfge
either
without
blot
hybrid
util
analysi
complex
dna
genom
varieti
respiratori
pathogen
rflp
analysi
also
appli
pcr
rtpcr
product
respiratori
bacteria
virus
gener
method
provid
resolut
subtyp
level
proven
use
outbreak
investig
illustr
figur
b
pertussi
isol
difficulti
gelbas
type
assay
pfge
standard
result
share
data
laboratori
amplifi
fragment
length
polymorph
aflp
analysi
repres
altern
method
better
discriminatori
power
portabl
approach
use
extens
respiratori
isol
date
respiratori
virus
method
use
type
includ
heteroduplex
mobil
assay
hma
singlestrand
conform
polymorph
sscp
rflp
analysi
amplifi
pcr
product
gener
hma
consid
technic
complex
capac
distinguish
viral
quasispeci
nucleotid
differ
sscp
rflp
technic
easier
gener
resolv
virus
subtyp
level
rflp
ad
constraint
assess
sequenc
differ
restrict
site
use
sequenc
assess
relationship
among
virus
well
establish
molecular
phylogenet
knowledg
expand
allow
model
viral
popul
predict
new
outbreak
level
resolut
use
primari
sequenc
one
genom
point
mutat
identifi
sometim
provid
inform
origin
sought
creat
problem
interpret
circumst
even
small
sequenc
variat
confer
import
chang
viral
transmiss
diseas
outcom
identif
emerg
virus
may
recent
introduc
human
popul
eg
sarscov
influenza
type
critic
public
health
analysi
novel
virus
reli
heavili
sequenc
isol
amplicon
human
influenza
virus
associ
enhanc
morbid
mortal
compar
influenza
b
influenza
c
virus
differ
pathogen
subtyp
influenza
also
report
exampl
associ
sever
infect
type
subtyp
influenza
circul
independ
identif
import
assess
current
vaccin
efficaci
reassort
two
predomin
influenza
subtyp
infect
human
recent
time
report
analysi
main
hemagglutinin
ha
type
undertaken
rang
molecular
nonmolecular
method
emphas
need
detail
surveil
influenza
virus
vigil
identif
emerg
virus
import
public
health
detail
analysi
avian
virus
infect
human
date
confirm
gene
avian
origin
associ
minim
ineffici
humantohuman
spread
potenti
reassort
virus
could
easili
spread
among
human
clear
molecular
method
import
part
influenza
surveil
recent
studi
human
metapneumoviru
identifi
two
main
lineag
sequenc
divers
within
group
figur
thu
display
similar
pattern
rsv
isol
classifi
two
major
group
b
studi
confirm
whether
distinct
associ
differ
virul
sequenc
analysi
type
bacteria
slower
develop
virus
util
investig
atyp
bacteria
associ
outbreak
respiratori
infect
eg
legionella
due
problem
recombin
character
singl
bacteri
gene
often
reflect
organ
whole
multilocu
sequenc
type
strategi
address
appear
use
analysi
b
pertussi
microarray
hybrid
method
use
identifi
differenti
relat
pathogen
approach
use
first
identifi
agent
sar
coronaviru
molecular
method
provid
addit
inform
virul
type
infecti
organ
illustr
recent
experi
sarscov
influenza
type
molecular
test
advantag
convent
procedur
sensit
molecular
amplif
method
lead
problem
interpret
result
mani
organ
gold
standard
method
avail
accur
reflect
enhanc
sensit
molecular
method
seen
pcr
test
b
pertussi
c
pneumonia
clinic
sampl
studi
confirm
pcr
test
sensit
pcrposit
individu
may
cultur
neg
asymptomat
result
must
alway
interpret
clinic
context
inhibitor
amplif
common
respiratori
specimen
neg
result
must
interpret
context
nucleic
acid
extract
method
control
result
monitor
nucleic
acid
degrad
amplif
inhibit
assay
detect
respiratori
pathogen
design
primer
probe
crossreact
normal
respiratori
flora
respiratori
pathogen
triag
molecular
test
respiratori
infect
diagnosi
difficult
current
singl
respiratori
pathogen
test
detect
one
relat
pathogen
also
bacteri
test
viral
test
combin
thu
mani
molecular
test
must
use
screen
appropri
pathogen
increas
test
cost
thu
laboratori
embark
use
molecular
method
diagnosi
respiratori
infect
may
requir
complex
test
algorithm
one
approach
use
multiplex
amplif
procedur
identifi
multipl
pathogen
singl
assay
certain
assay
commerci
avail
unfortun
test
tend
expens
develop
laboratori
difficult
control
ensur
equal
sensit
specif
pathogen
thu
despit
potenti
replac
mani
cultur
antigen
procedur
nucleic
acid
amplif
assay
molecular
diagnost
revolut
yet
happen
except
new
pathogen
nucleic
acid
amplif
detect
method
clearli
far
superior
altern
eg
metapneumoviru
sarscov
test
sampl
suboptim
routin
procedur
eg
surveil
situat
respiratori
infect
current
underdiagnos
despit
fact
accur
pathogen
identif
import
ensur
appropri
patient
manag
monitor
infecti
trend
commun
major
stumbl
block
diagnosi
investig
respiratori
infect
complex
test
algorithm
number
potenti
target
caus
upper
lower
respiratori
tract
symptom
realtim
pcr
method
vastli
improv
sensit
detect
recognit
difficulttocultur
organ
like
becom
standard
practic
clinic
laboratori
next
year
howev
limit
mani
organ
multiplex
singl
test
microarray
hybrid
randomli
amplifi
pcr
product
respiratori
cultur
clinic
sampl
shown
success
promis
earli
experi
maintain
appli
largescal
clinic
studi
could
answer
technic
problem
surround
use
multiplex
system
microarray
hybrid
current
conveni
realtim
pcr
detect
method
potenti
benefit
abl
resolv
complex
product
mixtur
provid
clinic
valuabl
inform
use
molecular
method
type
outbreak
investig
respiratori
pathogen
public
health
import
well
establish
like
expand
futur
direct
incorpor
use
microarray
system
respiratori
pathogen
detect
analysi
allow
cross
barrier
convent
virolog
bacteriolog
mycologyparasitolog
microarray
system
develop
valid
cost
enhanc
technolog
may
reduc
justifi
identif
novel
virus
presum
recent
introduc
human
reinforc
need
care
surveil
emerg
respiratori
pathogen
institut
appropri
infect
control
measur
lesson
learn
continu
sensit
surveil
type
organ
influenza
b
pertussi
direct
use
efficaci
avail
vaccin
molecular
techniqu
develop
detect
analysi
microb
respons
respiratori
infect
vital
understand
pathogen
mechan
appropri
manag
prevent
outbreak
futur
gelbas
type
procedur
pfge
hma
sscp
slowli
replac
sequencebas
altern
eg
multilocu
sequenc
type
mlst
amen
standard
share
data
among
laboratori
